Physician profile
Micah Derby
NPI 1548605199
$6,646.78
in general payments reported to CMS, 2019-2025
40 companies · $997 in 2025
The $997 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $577 · 2021: $1,062 · 2022: $1,503 · 2023: $1,131 · 2024: $334 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,462.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $2,097.71 | 2019-2025 | Yeztugo, Epclusa, Biktarvy |
| Viiv Healthcare Company | $1,011.65 | 2019-2025 | Cabenuva, Dovato, Rukobia |
| Janssen Biotech, INC. | $402.77 | 2019-2023 | Symtuza |
| Astrazeneca Pharmaceuticals LP | $381.42 | 2020-2023 | Andexxa |
| Insulet Corporation | $339.89 | 2023-2025 | Omnipod, Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.59 | 2019-2023 | |
| Janssen Products, LP | $198.95 | 2019-2021 | |
| Pfizer INC. | $195.05 | 2019-2022 | |
| Abbvie INC. | $185.37 | 2021-2023 | Avycaz, Vraylar |
| Novo Nordisk INC | $152.68 | 2019-2025 | |
| Teleflex LLC | $148.62 | 2025 | Urolift |
| Medtronic Minimed, INC. | $135.68 | 2019 | |
| Merck Sharp & Dohme LLC | $130.40 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Lilly USA, LLC | $127.38 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.48 | 2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Derby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.